<p>Mann–Whitney U-test. All data are medians and in-terquartile ranges (IQR). Significantly higher in stroke patients as compared to control cases (P<0.0001).</p
<p>Mann–Whitney U-test. All data are medians and interquartile ranges (IQR). Significantly higher in...
Abstract Background Insulin-like growth factor I (IGF-I) has neuroprotective effects in experimental...
Objective: Many stroke patients make a partial recovery in function during the first 3 months, partia...
Background and Purpose-Insulin-like growth factor I (IGF-I) is neuroprotective in animal models of s...
Background and Purpose—Insulin-like growth factor I (IGF-I) is neuroprotective in animal models of s...
The aim of the study was to assess the relationship between insulin-like growth factor I (IGF-I) ser...
OBJECTIVE: The aim of the study was to assess the relationship between insulin-like growth factor I ...
Abstract Background Cerebrovascular ischemic stroke is highly prevalent in the general population an...
Objective: Insulin-like growth factor-1 (IGF-1) has been associated with cardiovascular risk factors...
Insulin-like growth factor-1 (IGF-1) has been associated with cardiovascular risk factors and athero...
<p>Mann–Whitney U-test. All data are medians and in-terquartile ranges (IQR). Significantly higher i...
To examine whether serum insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) co...
<p>Mann–Whitney U-test. All data are interquar-tile ranges (IQR). Significantly higher in poor as co...
Serum insulin-like growth factor I (IGF-I), which is mostly produced by the liver, has recently been...
<p>(a) Correlation between the serum IGF-1 levels and the National Institutes of Health Stroke Scale...
<p>Mann–Whitney U-test. All data are medians and interquartile ranges (IQR). Significantly higher in...
Abstract Background Insulin-like growth factor I (IGF-I) has neuroprotective effects in experimental...
Objective: Many stroke patients make a partial recovery in function during the first 3 months, partia...
Background and Purpose-Insulin-like growth factor I (IGF-I) is neuroprotective in animal models of s...
Background and Purpose—Insulin-like growth factor I (IGF-I) is neuroprotective in animal models of s...
The aim of the study was to assess the relationship between insulin-like growth factor I (IGF-I) ser...
OBJECTIVE: The aim of the study was to assess the relationship between insulin-like growth factor I ...
Abstract Background Cerebrovascular ischemic stroke is highly prevalent in the general population an...
Objective: Insulin-like growth factor-1 (IGF-1) has been associated with cardiovascular risk factors...
Insulin-like growth factor-1 (IGF-1) has been associated with cardiovascular risk factors and athero...
<p>Mann–Whitney U-test. All data are medians and in-terquartile ranges (IQR). Significantly higher i...
To examine whether serum insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) co...
<p>Mann–Whitney U-test. All data are interquar-tile ranges (IQR). Significantly higher in poor as co...
Serum insulin-like growth factor I (IGF-I), which is mostly produced by the liver, has recently been...
<p>(a) Correlation between the serum IGF-1 levels and the National Institutes of Health Stroke Scale...
<p>Mann–Whitney U-test. All data are medians and interquartile ranges (IQR). Significantly higher in...
Abstract Background Insulin-like growth factor I (IGF-I) has neuroprotective effects in experimental...
Objective: Many stroke patients make a partial recovery in function during the first 3 months, partia...
DOI
Add to ORKG